Psoriatic arthritis as a mountain

Reumatismo

Volumn 55, Issue 1, 2003, Pages 6-15

  Berthelot, Jean Marie ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Enthesis; Genetics; Nosology; Psoriasis; Psoriatic arthritis

Indexed keywords

CYTOKINE;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FAMILIAL DISEASE; GENETIC RISK; HEREDITY; HUMAN; IMMUNOGENETICS; INJURY; PATHOGENESIS; PSORIATIC ARTHRITIS; REVIEW; RISK FACTOR; VASCULARIZATION;

ACQUIRED HYPEROSTOSIS SYNDROME; ANIMAL; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; COMPARATIVE STUDY; CYCLOSPORINS; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; ENDOTHELIAL GROWTH FACTORS; FOLLOW-UP STUDIES; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MIDDLE AGE; PROSPECTIVE STUDIES; PSORIASIS; RATS; RESEARCH; RISK FACTORS; SPONDYLARTHRITIS; TIME FACTORS;

EID: 0037231908     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (126)

1. Stern RS. The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 1985; 12: 315-20.
2. Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000; 27: 1247-50.
3. Gladman DD. Psoriatic arthritis: recent advances in pathogenesis and treatment. Rheum Dis Clin North Am 1992; 18: 247-56.
4. Green L, Meyers OL, Gordon W, Briggs B. Arthritis in psoriasis. Ann Rheum Dis 1981; 40: 366-9.
5. Little H, Harvie JN, Lester RS. Psoriatic arthritis in severe psoriasis. Can Med Assoc J 1975; 112: 317-21.
6. Scarpa L, Del Puente A, Di Girolamo C, Della Valle G, Lubrano E, Oriente P. Interplay between environmental factors, articular involvement, and HLA-B27 in patients with psoriatic arthritis. Ann Rheum Dis 1992; 51: 78-9.
7. Winchester R. Psoriatic arthritis. Dermatol Clin 1995; 13: 779-862.
8. Gladman DD. Psoriatic arthritis. Bailliére's Clin Rheumatol 1995; 9: 319-29.
9. Moll JMN, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 51-78.
10. Avila R, Pugh DC, Slocumb C, Winkelmann RK. Psoriatic arthritis: a roentgenologic study. Radiology 1960; 75: 691-702.
11. Jones SM, Armas JB, Cohen MG, Lowell CR, Evison G, McItugh NJ. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994; 34: 834-9.
12. Veale D, Rogers S, Fitzgerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994; 35: 133-8.
13. Fournié B, Granel J, Bonnet M, Dromer C, Pages M, Billey T, et al. Fréquence des signes évocateurs d'un rhumatisme psoriasique dans l'atteinte radiologique des doigts et des orteils. A propos de 193 cas d'arthropathie psoriasique. Rev Rhum Mal Ostéoartic 1992; 59: 177-80.
14. Fournié B. Le territoire enthésitique et le syndrome d'hyperostose-ostéite-périosteite (HOP). Une approche nosologique radioclinique des spondylarthropathies inflammatoires. Rev Rhum 1993; 60: 485-8.
15. Fournié B, Viraben R, Durroux R, Lassoued S, Gay R, Fournié A. L'onycho-pachydermopériostite psoriasique du gros orteil. Etude anatomoclinique et approche physiopathogénique. A propos de quatre observations. Rev Rhum Mal Ostéoartic 1989; 56: 579-82.
16. Salvarini C, Macchioni P, Cremonesi T, Mantovani W, Battistei B, Rossi F et al. The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study. Ann Rheum Dis 1992; 51: 73-7.
17. Jeannou J, Goupille P, Avimadje MA, Zerkak D, Valat JP, Fouquet B. Atteinte du rachis cervical au cours du rhumatisme psoriasique. Rev Rhum 1999; 66: 802-8.
18. Stevens KJ, Smith SL, Preston BJ, Deighton C. Tumoral enthesopathy in psoriasis. Rheumatology 2001; 40: 342-4.
19. Fournié A. Rhumatisme psoriasique. Rhumatologie 1968; 20: 13-9.
20. Wassenberg S, Fischer-Kahle V, Herborn G, Rau R. A method to score radiographic change in psoriatic arthritis. Z Rheumatol 2001; 60: 156-66.
21. Crognier L, Lalande Champetier de Ribes T, Railhac JJ. L'atteinte des doigts et des orteils au cours du rhumatisme psoriasique. Rev Rhum 2002; 69: 642-7.
22. Punzi L, Pianon M, Rossini P, Schiavon F, Gambari PF. Clinical and laboratory manifestations of elderly onset psoriatic arthritis: a comparison with younger onset disease. Ann Rheum Dis 1999; 58: 226-9.
23. Hofner R, Michels H. Psoriatic arthritis in children. Curr Opin Rheumatol 1996; 8: 467-72.
24. Taylor WJ. Epidemiology of psoriatic arthritis. Curr Opin Rheumatol 2002; 14: 98-103.
25. Lioté F. Pathogénie du Rhumatisme psoriasique. Rev Rhum 2002; 69: 608-14.
26. Costello PJ, Winchester RJ, Curran SA, Peterson KS, Kane DJ, Bresnihan B, et al. Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T clonal expansions that appear antigen driven. J Immunol 2001; 166: 2878-86.
27. Sarzi-Puttini P, Cazzola M, Panni B, Turiel M, Fiorini T, Belai-Beyene N, et al. Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis. Rheumatol Int 2002; 21: 234-8.
28. Krueger GG. Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis. Expert Opin Biol Ther 2002; 2: 431-41.
29. McInnes IB, Illei GG, Danning CL, Yarboro CH, Crane M, Kuroiwa T, et al. IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J Immunol 2001; 167: 4075-82.
30. Dunky A, Neumuller J, Menzel J. Interaction of lymphocytes from patients with psoriatic arthritis or healthy controls and cultured endothelial cells. Clin Immunol Immunopathol 1997; 85: 297-314.
31. Pitzalis C, Cauli A, Pipitone N, Smith C, Barker J, Marchesoni A, et al. Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joints in psoriatic arthritis. Arthritis Rheum 1996; 39: 137-45.
32. Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis. Analysis of 221 patients with active psoriatic arthritis. J Rheumatol 1999; 26: 1752-6.
33. Wrone-Smitn T, Nickoloff BJ. Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996; 98: 1878-87.
34. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. the american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
35. Gorter S, van der Heijde DM, van der Linden S, Houben H, Rethans JJ, Scherpbier AJ, et al. Psoriatic arthritis: performance of rheumatologists in daily practice. Ann Rheum Dis 2002; 61: 219-24.
36. Helliwell PS, Hetthen J, Sokoll K, Marchesoni A, Lubrano E, Veale D, et al. Joint symmetry in early and late rheumatoid and psoriatic arthritis. Comparison with a mathematical model. Arthritis Rheum 2000; 43: 865-71.
37. Helliwell P, Marchesoni A, Peters M, Barker M, Wright V. A reevaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 1991; 30: 339-45.
38. Jones SM, Armas JB, Cohen MG, Lowell CR, Evison G, McItugh NJ. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994; 34: 834-9.
39. McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum 1999; 42: 1080-6.
40. Berthelot JM, Klarlund M, Mcgonagle D, BernelotMoens HJ, Calin A, Harrison B, et al. Lessons from an international survey of paper cases from ten real early-arthritis-clinic patients. J Rheumatol 2001; 28: 975-81.
41. Dougados M, Van Der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al: The European Spondylarthropathy Study Group.-The European Spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 1218-26.
42. Amor B, Dougados M, Mijiyawa M: Critères de classification des spondylarthropathies. Rev Rhum Mal Ostéoartic 1990; 57: 85-9.
43. Berthelot JM, Saraux A, Maugars Y, Prost A, Le Goff P. The taxonomy-nosology of arthritis: the experience of early-arthritis clinic. Seminars. Arthritis Rheum 2001; 30: 354-65.
44. Sampaio-Barros PD, Bertolo MB, Kraemer MH, Marques-Neto JF, Samara AM. Undifferentiated spondylarthroarthropathies: a 2-year follow-up study. Clin Rheumatol 2001; 20: 201-6.
45. Kumar A, Bansal M, Srivastava DN, Pandhi A, Menon A, Mehra NK, et al: Long-term outcome of undifferentiated spondylarthropathy. Rheumatol Int 2001; 20: 221-4.
46. Bennet RM. Psoriatic arthritis. In: McCarty DJ, Ed. Arthritis and related conditions. Philadelphia: Lea And Febiger; 1979. p 645.
47. Vasey FB, Espinoza LR. Psoriatic arthropathy. In Calin A, Ed. Spondylarthropathies. New York: Grune and Stratton; 1984. p. 151-85.
48. Gladman DD, Schuckett R, Russel ML, Thorne JC, Schachter RK. Psoriatic arthritis. An analysis of 220 patients. QJ Med 1987; 238: 127-41.
49. Palazzo E. Critères de classification du rhumatisme psoriasique. Rev Rhum 2002; 69: 635-9.
50. McGonagle D, Conaghan PG, Emery P. Psoriatic arthritis. A unified concept twenty years on. Arthritis Rheum 1999; 42: 1080-6.
51. Fournié B, Crognier L, Arnaud C, Zabraniecki L, Lascaux-Lefebvre V, Marc V, et al. Proposition de critères de classification du rhumatisme psoriasique. Etude préliminaire de 260 patients. Rev Rhum; 1999; 66: 513-24.
52. Berthelot JM, Saraux A, Maugars Y, Le Goff P. The Fuzzy nosology of early rheumatoid arthritis and early spondylarthropathies: square classifications produced by circular reasoning? Joint Bone Spine 2001; 68: 285-9.
53. Berthelot JM, Bernelot-Moens HJ, Klarlund M, McGonagle D, Calin A, Schumacher HR, et al. Differences in understanding and application of 1987 ACR criteria for rheumatoid arthritis and 1991 ESSG criteria for spondylarrthropathy. A pilot survey. Clin Exp Rheumatol 2002; 20: 145-50.
54. Harrison BJ, Silman AJ, Barrett EM, Scott DGL, Symmonds DPM. Presence of psoriasis does not influence the presentation of short-term outcome of patients with early inflammatory polyarthritis. J Rheumatol 1997; 24: 1744-7.
55. Van Romunde LKJ, Cats A, Hermans J, Valkenberg HA. Psoriasis and arthritis II: a cross-sectional comparative study of patients with "psoriatic arthritis" and seronegative and seropositive polyarthritis: clinical aspects. Rheumatol Int 1984; 4: 61-5.
56. Said-Nahal R, Miceli-Richard C, D'agostino MA, Denis-Labous E, Berthelot JM, Duche A, et al. Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy. Arthritis Rheum 2001; 45: 478-84.
57. Berthelot JM, Wendling D, Combe B, Le Loet X, Saraus A, pour le CRI. Performances des critères 1987 de polyarthrite rhumatoïde de l'American College of Rheumatology dans le contexte des arthrites débutantes: étude de la littérature. Rev Rhum 2002; 69: 128-34.
58. Saraux A, Berthelot JM, Chalès G, Le Henaff C, Thorel JB, Hoang S, et al. Ability of the american college of rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 2001; 44: 2485-91.
59. Bruce IN, Silman AJ. The aetiology of psoriatic arthritis. Rheumatology 2001; 40: 363-6.
60. Gerard HC, Wang Z, Wang GF, El-Gabalawy H, Goldbach-Mansky R, Li Y, et al. Chromosomal DANN from a variety of bacterial species is present in synovial tissue from patients with various forms of arthritis. Arthritis Rheum 2001; 44: 1689-97.
61. Sibilia J, Limbach FX. Reactive arthritis or chronic infectious arthritis? Ann Rheum Dis 2002; 61: 580-7.
62. Berthelot JM, Glemarec J, Guillot P, Laborie Y, Maugars Y. New pathogenic hypotheses for spondyloarthropathies. Joint Bone Spine 2002; 69: 114-22.
63. Punzi L, Pianon M, Pozzuoli A, Oliviero F, Salvati GP, Gambari PF. Psoriatic arthritis exacerbated by Salmonella infection. Clin Rheumatol 2000; 19: 167-8.
64. Symmons D. Diagnostic criteria for early arthritis. Ann Rheum Dis 2002; 61 (Suppl 1); 2.
65. Rahman P, Nguyen E, Cheung C, Schentag CT, Gladman DD. Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis. J Rheumatol 2001; 28: 1041-4.
66. Sokoll KB, Heliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001; 28: 1842-6.
67. Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001; 45: 151-8.
68. Gladman DD, Hing EN, Schentag CT, Cook RJ. Remission in psoriatic arthritis. J Rheumatol 2001; 28: 1045-8.
69. Goupille P. Which second-line treatments are optimal in psoriatic arthritis? Joint Bone Spine 2002; 69: 244-8.
70. Wollina U, Konrad H. Treatment of recalcitrant psoriatic arthritis with anti-tumor necrosis factor-alpha antibody. J Eur Acad Dermatol Venereol 2002; 16: 127-9.
71. Braun J, de Keyser F, Brandt J, Mielants H, Sieper J, Veys E. New treatment options in spondylarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy. Curr Opin Rheumatol 2001; 13: 245-9.
72. Schopf RE, Aust H, Knop J. Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha, infliximab. J Am Acad Dermatol 2002; 46: 886-91.
73. Guedjonsson JE, Karason A, Antonsdottir AA, Runarsdottir EH, Gulcher JR, Stefansson K, et al. HLA-Cw6-positive and HLA-Cw6-negative patients with psoriasis vulgaris have distinct clinical features. J Invest Dermatol 2002; 118: 362-5.
74. Kahn MF. Frontières et confins du rhumatisme psoriasique. Rev Rhum 2002; 69: 682-4.
75. Maugars Y, Berthelot JM, Ducloux JM, Prost A. SAPHO syndrome: a follow-up study of 19 cases with special emphasis on enthesis involvement. J Rheumatol 1995; 22: 2135-41.
76. Zabraniecki L, Sans N. L'ostéomyélite aseptique du rhumatisme psoriasique. Rev Rhum 2002; 69: 654-6.
77. Hayem G, Bouchaud-Chabot A, Beanli K, Roux S, Palazzo E, Silbermann-Hoffman O, et al. SAPHO syndrome: a long term follow-up study of 120 cases. Semin Arthritis Rheum 1999; 29: 159-71.
78. Grossin M, Hayem G. Anatomopathologie synoviale et liquide articulaire. Rev Rhum 2002; 69: 624-9.
79. Reece RJ, Canete JD, Parsons WJ, Emery P, Veale DJ. Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 1999; 42: 1481-4.
80. Fiocco U, Cozzi L, Chieco-Bianchi F, Rigon C, Vezzù M, Favero E, et al. Vascular changes in psoriatic knee joint synovitis. J Rheumatol 2001; 28: 2480-6.
81. Kraan MC, Haringman JJ, Post WJ, Versendaal J, Breedveld FC, Tak PP. Immunohistological analysis of synovial tissue for differential diagnosis of early arthritis. Rheumatology 1999; 38: 1074-80.
82. Creamer D, Allen M, Jaggar R, Stevens R, Bicknell R, Barker J. Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor. Arch Dermatol 2002; 138: 791-6.
83. Ballara S, Taylor PC, Reusch P, Marme D, Feldmann M, Maini RN, et al. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum 2001; 44: 2055-64.
84. Cantini F, Salvarani C, Olivieri I, Macchioni L, Padula A, Falcone C, et al. Distal extremity swelling with pitting edema in psoriatic arthritis: a case-control study. Clin Exp Rheumatol 2001; 19: 291-6.
85. Creamer D, Jagger R, Allen M, Bicknell R, Barker J. Overexpression of the angiogenic factor platelet-derived endothelial cell growth-factor/thymidine phosphorylase in psoriatic epidermis. Br J Dermatol 1997; 137: 851-5.
86. Fearon U, Reece RJ, Blythe D, Jack A, Emery P, Veale DJ. Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients. Ann N Y Acad Sci 1999; 878: 619-21.
87. Freemont AJ, Denton J. Disease distribution of synovial fluid mast cells and cytophagocytic mononuclear cells in inflammatory arthritis. Ann Rheum Dis 1985; 44: 312-5.
88. Grisar J, Bernecker PM, Aringer M, Redlich K, Sedlak M, Wolozcszuk W, et al. Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis shows increased bone resorption, but differ with regard to bone formation. J Rheumatol 2002; 29: 1430-6.
89. Scarpa R, Del Puente A, di Girolamo C, della Valle G, Lubrano E, Oriente P. Interplay between environmental factors, articular involvement, and HLA-B27 in patients with psoriatic arthiritis. Ann Rheum Dis 1992; 51: 78-9.
90. Punzi L, Pianon M, Bertazzolo N, Fagiolo U, Rizzi E, Rossini P, Todesco S. Clinical, laboratory and immunogenetic aspects of post-traumatic psoriatic arthritis: a study of 25 patients. Clin Exp Rheumatol 1998; 16: 277-81.
91. Punzi L, Rizzi E, Pianon M, Rossini P, Gambari PF. Tattoing-induced psoriasis and psoriatic arthritis. Br J Rheumatol 1997; 36: 1133-4.
92. Riccieri V, Spadaro A, Taccari E, Zoppini A, Koo E, Ortutay J, et al. Adhesion molecule expression in the synovial membrane of psoriatic arthritis. Ann Rheum Dis 2002; 61: 569-70.
93. Reitchlin C, Haas-Smith SA, Hicks D, Cappucio J, Osterland CK, Looney RJ. Patterns of cytokine production in psoriatic synovium. J Rheumatol 1998; 25: 1544-52.
94. Fearon U, Reece R, Smith J, Emery P, Veale DJ. TGFB-1, VEGF and cytokines in early and late arthritis. Ann Rheum Dis 1999; 58 (Suppl): 53.
95. Spadaro A, Rinaldi T, Riccieri V, Valesini G, Taccari E. Interleukin 13 in synovial fluid and serum of patients with psoriatic arthritis. Ann Rheum Dis 2002; 61: 174-6.
96. Partsch G, Wagner E, Leeb BF, Bröll H, Dunky A, Smolen JS. T cell derived cytokines in psoriatic arthritis synovial fluids. Ann Rheum Dis 1998; 57: 691-3.
97. Wong WM, Howell WM, Coy SD, Cawley MI, Smith JL. Interleukin-2 is found in the synovium of psoriatic arthritis and spondyloarthritis, not in rheumatoid arthritis. Scand J Rheumatol 1996; 25: 239-45.
98. Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993; 36: 893-900.
99. Mellbye OJ, Shen Y, Hogasen K, Mollnes TE, Forre O. Adhesion molecule expression and complement activation in vessel walls in synovial tissue from patients with chronic inflammatory joint disease. Clin Rheumatol 1996; 15: 441-7.
100. Scotto di Fazano C, Grilo RM, Vergne P, Coyral D, Inaoui R, Bonnet C, Bertin P, et al. Is the relationship between spondyloarthropathy and Sjogren's syndrome in women coincidental? A study of 13 cases. Joint Bone Spine 2002; 69: 383-7.
101. Ahmed Q, Chung-Park M, Mustafa K, Khan MA. Psoriatic spondyloarthropathy with secondary amyloidosis. J Rheumatol 1996; 23: 1107-10.
102. Fearon U, Veale DJ. Pathogenesis of psoriatic arthritis. Clin Exp Dermatol 2001; 26: 333-7.
103. Veale D, Farrell M, Fitzgerald O. Mechanisms of joint sparing in a patient with unilateral psoriatic arthritis and a long standing hemiplegia. Br J Rheumatol 1993; 32: 413-6.
104. Eedy DJ, Johnston CF, Shaw C, Buchanan KD. Neuropeptides in psoriasis: an immunohistochemical and radioimmunoassay study. J Invest Dermatol 1991; 96: 434-8.
105. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85: 311-8.
106. Rashman P, Schentag CT, Gladman DD. Excessive paternal transmission in psoriatic arthritis. Arthritis Rheum 1999; 42: 1228-31.
107. Barton AC. Genetic epidemiology: psoriatic arthritis. Arthritis Res 2002; 4: 247-51.
108. Barton AC, Bruce IN, Silman AJ. Genetic studies of psoriatic arthritis: dissecting joints and skin. J Rheumatol 2001; 28: 3-5.
109. Gonzalez S, Martinez-Borra J, Lopez-Vazquez A, Garcia-Fernandez S, Torre-Alonso JC, Lopez-Larrea C. MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. J Rheumatol 2002; 29: 973-8.
110. Burden AD, Javed S, Bailey M, Hodgins M, Connor M, Tillman D. Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p. J Invest Dermatol 1998; 110: 958-60.
111. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE, Balish E, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human b2microglobulin transgenic rats. J Clin Invest 1996;98:945-53.
112. Onderdonk AB, Richardson JA, Hammer RE, Taurog JD. Cecal microflora of HLA-B27 transgenic rats: correlation with inflammatory bowel disease. Infect Immun 1998;66:6022-3.
113. Taurog J, Maika SD, Satumtira N, Dorris ML, McLean IL, Yanagisawa H. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 1999; 169: 209-23.
114. Prinz J. Psoriasis vulgaris-a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis. Clin Exp Dermatol 2001; 26: 326-32.
115. Muto M, Fujikura Y, Hamamoto Y, Ohmura A, Sasazuki T, Fukumoto T, et al. Immune response to Streptococcus pyogenes and the susceptibility to psoriasis. Australas J Dermatol 1996; 37 Suppl 1: S54-5.
116. Thomssen H, Hoffmann B, Schank M, Elewaut D, Meyer zum Buschenfelde KH, Marker-Hermann E. There is no disease-specific role for streptococci-responsive synovial T lymphocytes in the pathogenesis of psoriatic arthritis. Med Microbiol Immunol 2000; 188: 203-7.
117. Kaluza W, Meyer zum Buschenfelde KH, Galle PR, Marker-Hermann E. Synovial fluid lymphocyte proliferation in response to crude microbial antigens is not useful as a diagnostic test to specifically indicate a bacterial cause of arthritis. Clin Exp Rheumatol 2000; 18: 39-46.
118. Rantakokko K, Rimpilainen M, Uksila J, Jansen C, Luukkainen R, Toivanen P. Antibodies to streptococcal cell wall in psoriatic arthritis and cutanenous psoriasis. Clin Exp Rheumatol 1997; 15: 399-404.
119. Vaseu FB, Deitz C, Fenske NA, Germain BF, Espinoza LR. Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. J Rheumatol 1982; 9: 719-22.
120. Wang Q, Vasey FB, Mahfood JP, Valeriano J, Kanik KS, Anderson BE, Bridgeford PH. V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis. Arthritis Rheum 1999; 42: 2055-9.
121. Straus C, Caplanne D, Bergemer AM, Le Parc JM. Destructive polyarthritis due to a group B streptococcus. Rev Rhum 1997; 64: 339-41.
122. Huang DF, Tsai CY, Tsai YY, Liu RS, Yang AH, Chou CD. Reiter's syndrome caused by Streptococcus viridans in a patient with HLA-B27 antigen. Clin Exp Rheumatol 2000; 18: 394-6.
123. Lapadula G, Iannone F, Covelli M, Numo R, Pipitone V. Anti-enterobacteria antibodies in psoriatic arthritis. Clin Exp Rheumatol 1992; 10: 461-6.
124. Yamamoto T, Katayama I, Nishioka K. Peripheral blood mononuclear cell proliferative response against staphylococcal superantigens in patients with psoriatic arthropathy. Eur J Dermatol 1999; 9: 17-21.
125. Taglione E, Vatteroni ML, Martini P, Galluzzo E, Lombardini F, Delle Sedie A, et al. Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis. J Rheumatol 1999; 26: 370-2.
126. Scotet E, Peyrat MA, Saulquin X, Retiere C, Couedel C, Davodeau F, et al. Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur J Immunol 1999; 29: 973-85.